Hero or Villain – Are SGLT2 Inhibitors Your Patients’ BFF or Something to Be Cautious Of?
Hero or Villain – Are SGLT2 Inhibitors Your Patients’ BFF or Something to Be Cautious Of? Lessons from Current Guidelines and ASN Speakers: Professor Sophia Zoungas, Professor Carmel Hawley, Professor